Neoadjuvant Therapy for Early-Stage Breast Cancer: Current Practice, Controversies, and Future Directions
In this review, we will discuss multidisciplinary considerations in treating patients with neoadjuvant therapy and highlight areas of controversy and ongoing research.
Immune Targeting in Breast Cancer
The immune system is active in breast cancer, playing a dual role in tumor progression and in immune surveillance. Infiltrating immune cells are both prognostic and predictive of response to standard breast cancer therapies.
2 Clarke Drive Cranbury, NJ 08512